Product Pipeline

 

Innovative, exciting technology with extraordinary potential

Our pipeline currently centers on two promising compounds developed by world renowned Professors’ Chang and Han.

This platform drug as shown promise for the treatment of Acute Myeloid Leukemia.  Formally known as TPA, this platform small molecule has many potential therapeutic uses.  Rich Pharmaceuticals is exploring multiple indications for the highest likelihood of commercialization success that has the potential to become new compelling treatments for patients.

pipeline

News

June 21st, 2017

Rich Pharmaceuticals Announces Principal Doctor for Clinical Trials
View Release

June 8th, 2017

Rich Pharmaceuticals Announces Institutional Review Board Submission
View Release

May 31st, 2017

Rich Pharmaceuticals Announces Clinical Site in Thailand
View Release

» View All News

Stock Price